Bayesian Capital Management, LP Sarepta Therapeutics, Inc. Transaction History

Bayesian Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $1.24 Million - $1.49 Million	12,078 New	12,078 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $616,279 - $970,613	8,140 New	8,140 $900,000
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $807,886 - $1.14 Million	-12,887 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $813,814 - $1.17 Million	12,887 New	12,887 $1.01 Million
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $790,932 - $988,950	-11,400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $823,650 - $1.93 Million	11,400 New	11,400 $850,000
Q3 2019 Nov 13, 2019	SELL	$72.81 - $156.91 $211,149 - $455,039	-2,900 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $325,409 - $440,654	2,900 New	2,900 $441,000
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $416,845 - $583,858	-3,615 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $45,483 - $97,439	634 Added 21.27%	3,615 $478,000
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $161,033 - $245,246	2,981 New	2,981 $221,000
Q4 2017 Feb 12, 2018	SELL	$47.64 - $56.75 $867,048 - $1.03 Million	-18,200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $650,286 - $858,130	18,200	18,200 $826,000

534

85.3M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.68B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.